From Diagnosis to Development: How Point-of-Care Ultrasound Supports the 2030 UN Sustainable Development Goals

Sachita Shah, MD DTM&H1,2; Mena Ramos, MD3,4;Heather Harmon Donahoe, MPH2; Taiba Zahir, MPH2*; Shirish Rao, MBBS5; Sahra Sutaria2; Adi Nadimpalli, MD6; Nahreen Ahmed, MD MPH7; Lori Stolz, MD8

(1) Department of Emergency Medicine & Department of Global Health, University of Washington, Seattle, WA, USA

(2) Butterfly Network, Burlington, MA, USA

(3) Global Ultrasound Institute, Walnut Creek, CA, USA

(4) Department of Family and Community Medicine, University of California San Francisco, San Francisco, CA, USA

(5) Association for Socially Applicable Research (ASAR), Pune, Maharashtra, India

(6) Critical Care Medicine, Holy Family Hospital, Methuen, MA, USA

(7) University of Pennsylvania Health System, Philadelphia, PA, USA

(8) Department of Emergency Medicine, University of Cincinnati, Cincinnati, OH, USA

*Corresponding Author: Taiba Zahir (email: tkzahir@gmail.com)


Download article PDF – POCUS Journal 2026;11(2):45-57

DOI: https://doi.org/10.24908/pocusj.v11i02.19992


Abstract

Point-of-care ultrasound (POCUS) is a low-cost, portable diagnostic modality that has rapidly evolved to meet diverse clinical needs in both high- and low-resource settings. This paper explores how POCUS aligns with and advances the United Nations Sustainable Development Goals (SDGs), particularly SDG 3, but also others such as SDG 4, 5, 8, 10, 11, 14, 15  and 17. By integrating evidence from multiple specialties, including maternal health, infectious diseases, non-communicable diseases, emergency care, and health workforce training, we position POCUS as a cross-cutting innovation with significant potential to strengthen health systems, improve equity, and enable early diagnosis and treatment in remote and underserved communities. Its ability to empower mid-level providers through task-shifting, and its use in primary care and emergency conditions, further enhances its alignment with the principles of universal health coverage. However, despite growing evidence and technical feasibility, the adoption of POCUS remains limited due to systemic challenges including lack of funding, fragmented implementation, inadequate training, and limited recognition in national diagnostic policies and regulations. We call global health stakeholders, policymakers, funders, regulators, and clinicians, to invest in an enabling ecosystem for POCUS. Aligning national strategies with international frameworks is critical to unleashing the full potential of POCUS as a tool for advancing equitable diagnostic access and accelerating SDG progress.

Introduction

Diagnostic imaging is an essential bridge in the path from patient presentation and illness to treatment and well-being, yet almost half of the global population lacks access to diagnostic imaging in their healthcare delivery [1]. A 2021 Lancet commission report estimates the proportion of individuals without access to diagnostic imaging in low-income countries is more pronounced at 81%, and that over 1 million premature deaths could be avoided annually in low- and middle-income countries (LMICs) by reducing diagnostic gaps for six priority conditions – diabetes, hypertension, HIV, tuberculosis, hepatitis B virus infection for pregnant women, and syphilis for pregnant women [1,2]. As the recent COVID-19 pandemic laid bare and amplified existing disparities, the time is now to equip healthcare professionals in vulnerable communities with powerful diagnostic tools to strengthen health systems and prepare for future health catastrophes in our ever-changing world.

Point of care ultrasound (POCUS) is a bedside clinical decision-making tool with many diagnostic and treatment-supportive uses across a variety of patient types, disease states, and medical specialties. This single tool can be used for diagnosis of conditions affecting maternal, neonatal, and pediatric conditions, as well as non-communicable, traumatic, and infectious diseases. The versatility this allows improves clinicians’ diagnostic ability on many fronts. POCUS applications are designed with novice end-users in mind, making them accessible to a wide range of healthcare providers [3]. Recent technological advances have also miniaturized ultrasound machines to be as small as pocket-based, making them more portable and affordable than traditional machines [4]. This combination of increased clinician capacity and machine usability promotes the provision of high-quality care in any location, regardless of remoteness or resource availability and, when needed, facilitates timely, life-saving referrals.

These benefits are especially important in low resource environments where “task-shifting” of primary and emergency care towards mid-level, non-physician providers has been a strategy employed to address the shortage of medical specialists. By decreasing time and cost associated with making a diagnosis, rapid interventions early in a patient’s course of illness are possible, thereby improving cost effectiveness of care and triage of patients early in care to allow better stewardship of scarce resources.

When adopted at scale in LMICs with limited healthcare resources and large populations, POCUS has the capacity to catalyze major improvements in population health through improved access to quality healthcare and empowerment of healthcare providers. Moreover, POCUS can have significant planetary health benefits by reducing environmental waste through less reliance on other imaging modalities, reduced need for patient/provider travel through telemedicine applications, and overall improved access to diagnostic imaging in ‘last mile’ contexts [5]. 

One way progress towards population health is measured and goals are set by global policy makers is through the 2030 United Nations Sustainable Development Goals (SDGs). The SDGs are a collection of 17 interlinked objectives designed by the United Nations (UN) to serve as a shared blueprint for “peace and prosperity for people and the planet” [6]. The SDGs are a comprehensive framework to address global challenges including poverty, inequality, climate change, environmental degradation, peace and justice. Specific targets under each of the goals are expected to be achieved globally and by individual UN member states by 2030, and reaching these targets are highly visible and globally commendable markers of commitment to well-being on Earth [6].

The funding landscape in global population health is often siloed into disease-specific pillars, however, global investment in multi-modal diagnostic tools will strengthen health systems, accelerate progress towards achievement of the SDGs, and benefit all sectors of the population at once. Widespread adoption of POCUS in the public sector at the country level has the capacity to drive progress on many of these goals, which are summarized below.

Sustainable Development Goal 3 – Good Health and Well-being

Target 3.1: By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births

POCUS can be used to identify high-risk conditions of pregnancy including pregnancy of unknown location, ectopic pregnancy, ruptured ectopic pregnancy, multiple pregnancy, placental abnormalities such as previa and abruption, abnormalities in level of amniotic fluid, abnormal fetal lie and presentation, and retained products of conception. It can also be used to accurately date a pregnancy and guide interventions for postpartum hemorrhage [7,8]. The World Health Organization (WHO) recommends one antenatal ultrasound scan before 24 weeks gestation for all pregnant people, and their policy calls out the importance of screening ultrasounds by lower-skilled antenatal providers as complimentary to complete sonography for more advanced uses. These screenings are more easily achieved with POCUS, even in austere environments [9]. Another benefit of routine ultrasound in antenatal care is that fetal imaging may encourage pregnant patients to seek care, improving visit attendance overall [10]. Additionally, educating antenatal care providers in POCUS allows for parallel education on high risk conditions of pregnancy and the peripartum period, improving the quality of care delivered by birth attendants by integrating POCUS training together with overarching clinical training [11].

Target 3.2: By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births

Global progress towards reduction of neonatal mortality rates (NMR; number of live-born infants dying in the first 28 days of life per 1000 live births) has improved in many nations, however much work remains to achieve the SDG NMR targets by 2030 given setbacks in maternal care services in LMICs during the COVID-19 pandemic and disparities in access to healthcare worker attended deliveries in low-income countries [12,13,14,15].Neonatal mortality in LMICs is caused by three major conditions: asphyxia (e.g., from obstructed labor or placental abruption), infections (e.g., from prolonged time with rupture of membranes prior to delivery), and prematurity (e.g., unrecognized preterm labor due to unknown gestational age) [16,17]. Late-term POCUS helps providers identify risk factors for obstructed labor such as malpresentation or macrosomia, to ensure consideration of birth plans for those conditions such as cesarean section or vacuum assisted delivery. In a 2023 study of a quick bedside scan during labor, malpresentation was identified in a large proportion of patients leading to actual impact on neonatal mortality and APGAR scores [7]. POCUSto establish gestational age in a patient with potential preterm labor can inform clinicians to administer steroid treatment for lung maturation decreasing risk of neonatal respiratory distress [18,19].

Under-5 mortality is driven by pneumonia and diarrheal illnesses, and POCUS applications are very useful for both conditions [20]. Repeated studies have shown that a pneumonia diagnosis can be made accurately with POCUS for all ages, and with better diagnostic sensitivity than X-ray or clinical diagnosis alone [21]. As for diarrheal diseases, appropriate fluid administration can be lifesaving and ultrasound can optimize this resuscitation in resource-scarce settings [22]. In addition, early identification of pediatric surgical diseases (e.g., intussusception) can be performed by clinicians using POCUS [23,24]. A single hand-held POCUS device can address these preventable causes of death from right before birth, in the newborn period, and into childhood to improve early identification to speed appropriate treatment and avert mortality.

Target 3.3: By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases

POCUS has a strong role to play in the diagnosis and treatment monitoring of patients with AIDS, Tuberculosis (TB), and co-infection. HIV remains a leading cause of death in LMICs, with women of reproductive age disproportionally infected [25]. While HIV may be considered a laboratory diagnosis, POCUS plays an important role in the diagnosis of the leading actual causes of death in AIDS patients including pneumonia, cardiomyopathy, nephropathy, and deep venous thrombosis. TB is one of the leading causes of mortality disease worldwide, registering approximately 1.6 million deaths in 2022 [26]. Yet the diagnosis of TB is still a challenge, especially in patients who have HIV/TB co-infection and are at higher risk of extra-pulmonary TB, which can go undetected by chest radiography. A novel and highly sensitive use of POCUS has been to help identify those patients with evidence of extra-pulmonary TB through the Focused Assessment with Sonography for HIV-associated TB (FASH) exams [27,28]. 

The role of POCUS with neglected tropical diseases (NTDs) is emerging. Diseases such as malaria, dengue fever, and Leishmaniasis can have dangerous consequences and are often difficult to manage in low-resource settings. POCUS can be used to help evaluate volume status and treat pulmonary edema in patients with malaria and it can be used to diagnose visceral leishmaniasis [29,30,31]. POCUS can be used to aid in the risk stratification of patients with suspected or confirmed Dengue. Mortality in Dengue cases is due to circulatory collapse and is often so severe and rapid that health facilities in low-resource settings cannot refer patients quickly enough. POCUS can identify plasma leakage prior to circulatory collapse, thereby allowing for early recognition and early management and, as in other disease processes, can aid in resource optimization for resuscitation [32,33].

Target 3.4: By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being

POCUS can be used to screen for and detect non-communicable disease. Worldwide, cardiovascular diseases including ischemic heart disease, stroke, and congestive heart failure are leading causes of death and disability affecting over 500 million patients in 2019 [34]. Diagnosis of heart failure is primarily made using echocardiography, and given the dearth of cardiologists and trained sonographers in LMICs, mounting evidence suggests early diagnosis and referral for care can improve outcome. Gross left ventricular (LV) function estimation to identify systolic LV dysfunction and basic valve assessment can be used to screen populations with dyspnea for heart failure or structural valve disease at the primary care level to expedite appropriate referral when cardiac care resources are scarce [35,36,37,38]. Other NCD use cases for POCUS include breast lump assessment (cyst vs solid mass for referral/biopsy), thyroid assessment (thyromegaly vs discrete mass or cyst for referral/biopsy), and pre-chemotherapy echocardiography for cardiovascular risk assessment prior to medication choice (as some chemotherapeutics can be cardiotoxic), which are currently integrated into cancer care programs in resource poor settings. POCUS can also detect emergent non-communicable conditions such as cholecystitis and other biliary disease, deep vein thrombosis, and pyelonephritis, facilitating timely management [39,40].

Target 3.6: By 2020, halve the number of global deaths and injuries from road traffic accidents

According to the WHO, injuries both unintentional and violence-related claim the lives of 4.4 million people each year with three of the top five causes of death in 5–29-year-olds listed as suicide, homicide, and road traffic accidents [41]. With POCUS, the extended Focused Assessment with Sonography in Trauma (eFAST) exam can be performed for evaluation of traumatic injury, speeding time to operative care. In the scenario of undifferentiated shock, POCUS can also play a part in differentiating the etiology, which also allows for informed use of crystalloids and blood products in resuscitation efforts [42].

In settings without easy access to computed tomography (CT) scanning, POCUS can be used to detect cerebral edema and elevated intracranial pressure in patients with traumatic brain injury [43,44,45]. In settings without easy access to radiography or fluoroscopy, POCUS can be used for fracture reduction and ultrasound guided regional anesthesia prior to orthopedic procedures [46]. Additionally, in surgical and trauma critical care units, POCUS guidance for procedures such as central venous catheterization and bladder catheterization, and evaluation of hemodynamic and cardiovascular status necessary for accurate fluid resuscitation are used world-wide [47].

Target 3.7: By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes.

A 2023 systematic review and meta-analysis of randomized controlled trials of ultrasound guidance for intrauterine device (IUD) placement suggests POCUS improves family planning effectiveness through reduced procedural complications, significantly fewer mispositioned IUDs, improved patient comfort and satisfaction, and decreased time for POCUS-guided IUD placement [48,49].Early diagnosis of ruptured hemorrhagic ovarian cysts through POCUS may speed access to care. Lastly, early confirmation of gestational age dating in intrauterine pregnancy can be valuable in settings with access to gestational age-sensitive abortion.

Target 3.8: Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all

A vast number of services benefit from improved safety, efficacy, and quality with POCUS integration (procedural guidance, staged imaging, reducing need for additional diagnostic tests, etc). POCUS has the capacity to reduce healthcare expenditures or end-user fees through decreasing the need for more expensive additional testing if POCUS screening is negative for disease, decreasing unnecessary healthcare visits if referrals do not need to be made, and lower cost-per-use, particularly with the affordability of hand-held ultrasound machines [50]. A recent article, from a high income country, suggests lung POCUS in patients with congestive heart failure can reduce length of hospital stay by guiding more efficient treatment plans, thereby reducing system cost [51].

Target 3.9: By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination

For many diagnoses, POCUS is an alternative to traditional X-ray, CT, or magnetic resonance imaging (MRI), reducing exposure to radiation and to hazardous chemicals associated with waste from these other imaging modalities. The advent of ultrasound on a microchip has led to the first compliance with the European Union’s Restriction of Hazardous Substances (RoHS) directive, whereas other ultrasound devices to date rely on an exemption to RoHS due to containing a level of lead in the piezoelectric crystals that exceeds the level deemed hazardous to humans and the environment [52]. With ever-improving technology, battery based POCUS devices can be more easily charged through renewable energy mechanisms and continue to work without active electricity [53].This is especially important given increasing recognition of harms of fossil fuel-based energy sources for health care delivery.

While POCUS has emerged as part of the 2023 revised global diagnostic criteria for acute respiratory distress syndrome (ARDS), lung ultrasound as a diagnostic tool for study of inhalation related pneumonitis from contaminated soil or air-borne tropical diseases (eg. histoplasmosis, or pneumoconiosis) requires further study [54]. POCUS can be used to assess blast or chemical injury to the lung in environments contaminated in war, where acute lung injury/ARDS incidence and prevalence in modern conflict range from 3% to 33%, with mortality ranging from 12.8% to 33% [55].

Target 3.c: Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States

One of the main challenges in providing health care in LMICs is the disadvantageous ratio of patients to healthcare providers. This deficit in trained healthcare providers is a major factor in healthcare disparities, with predictions of workforce shortages amplifying in the future leading to an anticipated deficit of 15 million providers worldwide by 2030 [56]. POCUS facilitates the upskilling of healthcare providers, including the development of local, in-country POCUS trainers, and helps to address this deficit [57]. Leveraging tele-guidance and tele-education platforms within app-based POCUS is an innovative training mechanism for care providers in developing countries and further augments this upskilling [58]. The portability of point of care ultrasound equipment allows last mile health workers access to diagnostic imaging even in remote settings, boosting capacity and care delivery. Finally, by increasing training opportunities and improving clinicians’ capacity to care for patients, POCUS directly addresses key factors related to ‘brain drain’ from austere settings [59].

Target 3.d: Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks

POCUS complements improved health systems strengthening through strengthened provision of emergency medicine services and early detection of emerging contagions, especially respiratory contagions. During the recent COVID-19 pandemic, POCUS played a significant role in screening, triage and ongoing management. Due to the portability and ease of disinfection, POCUS stood out as a preferred diagnostic imaging modality [60]. When coupled with digital health applications, hand-held ultrasound platforms could allow remote outbreak of respiratory illnesses to be alerted using national EMR and surveillance apps on the same host device used by the POCUS transducer for real-time monitoring. Lung ultrasound proved to be a valuable diagnostic tool in COVID-19 pneumonia [61, 62].

In summary, multiple POCUS use cases can guide diagnosis, treatment and management to drive progress towards subgoals of SDG 3. These gains are amplified and accelerated across most use cases with the introduction of embedded teleguidance within POCUS devices/software. The added benefit of POCUS are emerging solutions with cloud teleguidance capabilities which can allow for remote patient monitoring for chronic conditions as well as remote training for unique fit-to-purpose POCUS exams. In hard-to-reach areas of the world, where both access to diagnostics and availability of trained personnel is limited, remote capabilities of cloud/guidance-enabled POCUS can connect chronic disease providers worldwide and assist remote clinicians in diagnosis and longitudinal monitoring for patients with non-communicable diseases [63].

Sustainable Development Goal 4 – Ensure inclusive and equitable quality education and promote lifelong learning opportunities for all

Sustainable POCUS programs are unique in their inclusivity and equitability, with POCUS education programs providing a substantial cache of educational and multilingual educational content. Much of this free open access medical education content is available, allowing educational opportunities despite economic circumstance. A common model for POCUS education is a train-the-trainer program, which provides opportunities for career advancement and continuing education for those involved. While development of a sustainable POCUS training program must be individualized for context, learners, content, need and available resources, several key steps are well documented to lead to success [64].

Ideal programs for POCUS training begin with a partnership with local providers who can guide a needs assessment for identification of high-yield POCUS exam types, given the patient population and burden of disease. Working with a local POCUS champion and adhering to regional policy and guidelines (if any exist around POCUS), can allow true educational partnership in establishing POCUS services. Trainings must focus on basic POCUS technical expertise in image capture, image interpretation, and integrating these skills together with clinical decision-making to promote sustainable use and true adoption [64]. The addition of training on how to use the information from the images acquired to make timely and quality referrals, guide emergent patient care, and center health equity in daily patient interactions is paramount to successful integration of ultrasound services in a care setting. Furthermore, ongoing continuing medical education, professional development coursework, and longitudinal mentorship with feedback/quality assurance (QA) is important for care providers to harness the rapidly evolving improvements in POCUS technology. Finally, academic partners from the Global North should support research led by partners in the Global South to explore effective POCUS training methods, diagnostic accuracy of POCUS for various diseases, derivation and validation of AI-enabled POCUS in LMICs, and impact of introducing POCUS services on patient outcomes in LMICs.

Sustainable Development Goal 5: Achieve gender equality and empower all women and girls

Healthcare career options for women increase their economic independence and quality of life. Involving women in healthcare delivery not only provides stable long-term careers in communities where employment options for women may be limited but simultaneously increases the capacity for healthcare delivery in their communities. Though women make up 70% of the healthcare workforce in LMICs, they are rarely within the leadership of healthcare organizations [65]. The integration of POCUS into vocational and tertiary healthcare education provides an additional skill set to this cohort, increasing their economic stability, career options and expertise. 

Integration of POCUS into routine women’s healthcare enables improved patient understanding and decision-making around sexual and reproductive healthcare, perhaps leading to family planning options and ability to participate in the workforce outside the home [49].

Sustainable Development Goal 8: Promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all

POCUS training builds human resources for health, upskills mid-level providers, and enables task-shifting where appropriate. Relatively, POCUS can be an economically sustainable intervention for public-sector healthcare delivery settings given its low startup cost and ability to enhance revenue generation in medical practice. Anecdotal evidence suggests empowerment of healthcare workers with an easy-to-use clinical decision-making tool may mitigate healthcare worker burnout, especially following the COVID-19 pandemic, although no rigorous research has yet been published on this idea.

Sustainable Development Goal 10: Reduce inequality within and among countries & Sustainable Development Goal 11: Make cities and human settlements inclusive, safe, resilient and sustainable

POCUS addresses both SDG 10 and 11 in several ways. Within and between countries, POCUS improves healthcare systems and delivery in austere settings, including humanitarian crisis settings and migrant populations, where poor access to diagnostic tools and time-lags for appropriate referrals can diminish quality of care [66,67]. Among other benefits, this may mitigate health system overload and refugee health crises, which otherwise disproportionately affect poor and marginalized populations. POCUS for bedside diagnosis may also reduce the disparities between urban and rural health outcomes related to trauma, stroke and cardiac emergencies experienced even in high-income countries like the US.

POCUS enables health systems strengthening and improved resilience for disaster risk reduction and is ideally suited for mobile care delivery. This application allows remote and hard-to-reach areas globally to have access to high quality diagnostics, a point which is especially important to address maternal and child health in low resource settings.  Within cities and urban human settlements, the portability of POCUS allows care delivery to happen not only in public clinic settings but also further into communities in “street medicine” mobile units to reach urban homeless patients.

Sustainable Development Goals 14 & 15: Conserve and sustainably use the oceans, seas and marine resources for sustainable development & Protect, restore and promote sustainable use of terrestrial ecosystems, sustainably manage forests, combat desertification, and halt and reverse land degradation and halt biodiversity loss

POCUS’ veterinary applications enable protection of the health and well-being of animals, including livestock and marine mammals, and conservation of endangered species, particularly in the face of climate change and environmental degradation [68,69].  Healthy marine and land mammals are a vital part of marine habitats and ecosystems, and POCUS in veterinary medicine applications plays an important role in the reproductive assessment and health of these vital species in rehabilitation and protection facilities.

Sustainable Development Goal 17: Strengthen the means of implementation and revitalize the Global Partnership for Sustainable Development

POCUS is an ideal candidate for large-scale deployment by way of private-public partnerships and unique, more equitable financing models. SDG 17 includes investing in data and statistics, and the digitization of POCUS including ability of cloud-based technology to share real-time usage statistics to funders and policy makers makes it useful for data point gathering on health outcomes. Target 17.7.1 refers to dissemination and with the miniaturization (multiple vendors) of the physical footprint of POCUS, to the novel use of chip-based ultrasound technology, advancements in POCUS on-chip manufacturing (single vendor isolated) have virtually eliminated the use of lead in the production of the probes [70].

AI-Enabled POCUS

The next phase of large-scale POCUS adoption will likely be driven by Artificial Intelligence (AI). From automating educational tools to enhancing diagnostic speed and accuracy, AI and deep-learning algorithms have become central strategies for expanding POCUS access in underserved regions. Current innovations include AI-labeled image guidance and virtual reality walk-throughs embedded directly into ultrasound devices. Furthermore, cloud-based “smart QA” systems can provide initial AI-led screenings, potentially reducing the administrative burden on expert reviewers. Partnerships between industry and academia have further accelerated this progress by utilizing open software development kits to create interoperable, AI-driven applications for real-time image processing. A landmark University of North Carolina study funded by the Gates Foundation demonstrated this potential; novice midwives using a “blind sweep” method—without a visible ultrasound image—achieved gestational age estimates equivalent to expert sonographers [71]. Emerging research is also expanding POCUS applications to new diagnostic frontiers, such as using deep learning to detect pulmonary tuberculosis [72,73,74]. To ensure the safe and equitable global rollout of these technologies, future efforts must prioritize diverse patient inclusion in algorithm validation, the establishment of regulatory protocols in LMICs, and the maintenance of accessible software pricing.

Conclusions

As more low- and middle-income economies invest in medical technologies and community programming to reach the UN’s sustainable development goals, focus will turn to innovations that can address many goals at once. Many medical landscapes can be described as diagnostic deserts where clinicians rely heavily on physical exam skills and disease epidemiology/prevalence to make medical diagnoses, limiting their ability to make timely live-saving diagnoses and choose appropriate available treatments. POCUS devices that are compact and simple to use, paired with appropriate training for clinicians, are uniquely suited to address the major gap in diagnostic imaging in LMICs given their vast number of applications, affordability, and portability. Widespread adoption of POCUS as a diagnostic tool in medical care can influence much more than SDG 3 as it relates to health and well-being, as seen in Table 1. Indeed, for the WHO top causes of death in low-income countries, POCUS can be used for either diagnosis or management guidance for nearly every cause of death, as seen in Table 2 [75].

Table 1. Summary of Selected Sustainable Development Goals and the Role of Point of Care Ultrasound.
SDGRole of Point of Care Ultrasound
3. Good Health and Well-being3.1― POCUS can be used to identify high-risk conditions of pregnancy including placental abnormalities/abruption, retained products of conception with subsequent infection, identification of ectopic pregnancy/ruptured ectopic pregnancy, and postpartum complications.
3.2― Neonatal mortality is typically related to birth-related complications, which can be averted with early diagnosis in utero.
― Under-5 mortality is driven by pneumonia, which is a diagnosis that can be made with ultrasound. Fluid resuscitation in the setting of diarrhea can be facilitated in resource-scarce settings with ultrasound.
3.3― Ultrasound can be useful in the diagnosis and management (procedural guidance in relation to complications) in tuberculosis and HIV.
― Ultrasound can be diagnostically useful in treating malaria-induced or hepatitis-induced advanced complications.
― Ultrasound can be helpful in treating multiple NTDs, including leishmaniasis.
3.4― Ultrasound can be useful in the diagnosis of rheumatic heart disease, stroke/cardiovascular disease screening, and has oncology management applications.
3.6― The eFAST exam can be conducted with POCUS for evaluation of traumatic injury.
― Critical care also benefits from access to ultrasound, especially in the absence of CT Scans.
3.8― Benefits many services from improved safety, efficacy, and quality with ultrasound on board (procedural guidance, reducing need for additional diagnostic tests, etc.).
― POCUS in general is very affordable compared to standard ultrasound machines on the market – has the capacity to reduce healthcare expenditures or end-user fees.
3.9― Portable ultrasound is an alternative to traditional X-ray, reducing exposure to hazardous chemicals associated with X-ray.
― POCUS based on microconductor technology reduces lead-waste associated with PZE-crystal based ultrasound.
3.c― Upskilling of healthcare providers; development of local, in-country POCUS trainers.
― Portability of equipment allows last mile health workers access to diagnostic imaging even in remote settings.
3.d― Improved health systems strengthening through strengthened provision of emergency medicine and early detection of emerging contagions (especially respiratory contagions).
― Potential to strengthen and promote more resilient primary care systems, resulting in less medical migration.
4. Quality Education― Advancing vocational and tertiary education programs in the health sciences commonly pursued by women.
― Leveraging the trainer model (formal and organic), and open-access education content, to develop sustainable education programs for healthcare providers.
― Promoting knowledge and skills needed to promote sustainable development among POCUS learners.
5. Gender Equality― Enabling improved patient understanding and decision-making around sexual and reproductive healthcare.
8. Decent Work and Economic Growth― Building human resources for health, upskilling mid-level providers, and enabling task-shifting.
― Introducing an economically sustainable intervention into public-sector healthcare delivery settings.
― Mitigating healthcare worker burnout, particularly following the COVID-19 pandemic, through introduction of a simple, life-saving tool.
10. Reduced Inequalities― Improving healthcare in humanitarian crises settings, and among migrant populations, abating health system overload and refugee health crises.
11. Sustainable Cities & Environments― Health systems strengthening and resilience for disaster risk reduction.
― Enabling mobile, point-of-care medical services delivery.
14 & 15. Life Below Water and Life On Land― Veterinary applications enable protection of the health and well-being of animals, including livestock and marine mammals, and conservation of endangered species.
17. Strengthen Partnerships― Ideally suited for private/public partnerships for large-scale deployments.
― Digitization of health data through cloud-based POCUS can lead to real-time patient outcome information for policy and public health response
Table 2. POCUS exams and AI applications that could influence the top causes of death in low-income countries.
Top Cause of Death in Low-Income Countries (2023)POCUS Exam Type and AI applicationsEvidence
1. Lower Respiratory Infection— Pneumonia screening[54,84,85,86,21,
87,88,89,90,91]
— Parapneumonic effusion identification and guided drainage
— COVID-19 infection identification
— AI-guided B-lines
2. Stroke— Carotid and echo screening for cerebrovascular accident risk and prevention[92]
3. Ischemic Heart Disease— Echo screening for complications of heart failure with ischemic heart disease[38,93,94,95]
— Localized wall-motion abnormality as proxy for myocardial infarction
— AI-guided automatic ejection fraction
4. Malaria— Splenomegaly or elevated intracranial pressure from cerebral malaria[96,97,98]
— Volume status and edema in severe malaria
5. Diarrheal Diseases— Volume status and complications of dehydration/management of volume resuscitation[99,100,101,102]
— Nematode related bowel obstruction
6. Preterm birth complications— Early diagnosis of prenatal conditions[7]
— Identification of obstructed labor
7. Tuberculosis— Lung ultrasound for diagnosis of pulmonary TB[72,103,104,105,106,107,108,109]
— FASH exam for diagnosis of extrapulmonary TB
— Tuberculous meningitis and elevated intracranial pressure
8. Road Injury— eFAST exam for diagnosis of pneumothorax, hemothorax, hemoperitoneum, hemopericardium[110]
9. HIV/AIDS— Complications of HIV/AIDS including cardiomyopathy, nephropathy, pneumonia/interstitial disease, deep venous thrombosis, Kaposi sarcoma[111,112,113,114,115]
10. Birth Asphyxia and birth trauma— Malpresentation[7,116,117,118]
— Cephalo-pelvic disproportion

Challenges

Despite technological advancements and the increasing demand for large-scale POCUS integration to address diagnostic imaging gaps, significant implementation barriers persist. These include limited affordability, lack of specialized training, insufficient staffing, and physical infrastructure (including network services) [76]. While point of care ultrasound devices have reduced equipment costs, public healthcare systems in LMICs still struggle to procure necessary consumables like gel and paper towels. Educational barriers also remain substantial due to the high cost of training and the clinical time required for providers to achieve independent proficiency. Furthermore, limited infrastructure—including unreliable electricity, poor internet connectivity, and a lack of downstream specialty services like surgery or intensive care—continues to impede the success of global POCUS programs.

Barriers to Implementation

Over the past decade, the body of high-quality research in support of POCUS use in many of these medical conditions has expanded in quality and quantity. However, national and international policy lags behind the evidence and material need for improved diagnostics. Despite increasing evidence supporting the utility of POCUS, its global implementation is hindered by persistent legal, regulatory, and systemic barriers. In South Asia, for instance, India’s Preconception and Prenatal Diagnostic Techniques (PCPNDT) Act, originally aimed at curbing sex-selective practices, has inadvertently constrained clinical POCUS use due to strict restrictive regulations [77]. However, practical policy reforms, such as permitting image-archived scans, establishing clinical-use exemptions in emergency settings, and integrating audit mechanisms, could ensure ethical compliance while enabling access to essential diagnostics in underserved areas [77]. Similar limitations exist globally: in many LMICs, the absence of formal regulatory frameworks means POCUS remains unrecognized in national health strategies, and task-shifting to general physicians, nurses, or midwives remains unsupported [3,78]. However, structured, competency-based training programs have shown that non-physician providers can deliver high-quality POCUS, especially in obstetric and emergency care [79]. In parallel, remote supervision and AI-guided platforms offer scalable, low-cost solutions for quality assurance, particularly in resource-limited settings [80].

We commend the World Health Assembly 2023 resolution on diagnostics that has enabled prioritization of resources specifically to increase access to appropriate diagnostics, and we call for an acceleration of opportunities to allow innovative technologies to reach remote patients [81]. This effort by WHA was further enhanced in WHAs 2025 resolutions to strengthen medical imaging technologies in LMICs, as encouragement to MOH leads in LMICs to consider funding imaging diagnostics more broadly [82]. The United Nations has turned its lens to harness new technologies to accelerate progress towards the 2030 SDGs and we hope this manuscript provides a roadmap to focus all relevant stakeholders on POCUS as one of these technologies [83].

We hope that this review will serve as a call to action for funders, policymakers, market shapers, and Ministries of Health around the world to encourage recognition of POCUS as a diagnostic screening tool with value and acceptable return on investment across multiple provider levels and specialties. To date, siloed funding mechanisms that are geography- and disease-specific have limited adoption of diagnostic innovations in low- and middle-income contexts. We hope that, particularly in a post-COVID-19 context, a substantial shift in funding opportunities and management allows for wide scale uptake of innovations that improve whole-human health and strengthen health systems. Furthermore, we encourage adoption of POCUS into medical curriculums for all health care providers world-wide, such that it becomes as ubiquitous a tool as the stethoscope, and we implore decision-makers to make available equipment, training, and infrastructure to meet these recommendations.

Ethics Statement

This article does not involve human subjects. Therefore, it is exempt from ethics review.

Disclosure Statement

SS, HHD, TZ, & SS are affiliated with Butterfly Network, Inc. MR is affiliated with Global Ultrasound Institute.

Funding

No associated funding was received for this work.

Author Contributions

SSh: conceptualization, analysis, investigation, methodology, writing-original draft, visualization, writing-editing. MR: conceptualization, analysis, investigation, methodology, writing-original draft. HHD: conceptualization, analysis, investigation, methodology, writing-original draft. TZ: conceptualization, analysis, investigation, methodology, writing-original draft, writing-editing. SR: analysis, writing-editing. SSu: analysis, visualization, writing-editing. AN: analysis, investigation, methodology, writing-editing. NA: analysis, investigation, methodology, writing-editing. LS: analysis, investigation, methodology, writing-original draft.

References

1. Fleming KA, Horton S, Wilson ML, Atun R, DeStigter K, Flanigan J, Sayed S, Adam P, Aguilar B, Andronikou S, Boehme C, Cherniak W, Cheung ANY, Dahn B, Donoso-Bach L, Douglas T, Garcia P, Hussain S, Iyer HS, Kohli M, Labrique AB, Looi LM, Meara JG, Nkengasong J, Pai M, Pool KL, Ramaiya K, Schroeder L, Shah D, Sullivan R, Tan BS, Walia K. The Lancet Commission on diagnostics: Transforming access to diagnostics. Lancet 2021; 398(10315): 1998–2050.

2. Hricak H, Abdel-Wahab M, Atun R, Mikhail Lette M, Paez D, Brink JA, Donoso-Bach L, Frija G, Hierath M, Holmberg O, Khong PL, Lewis JS, McGinty G, Oyen WJG, Shulman LN, Ward ZJ, Scott AM. Medical imaging and nuclear medicine: A Lancet Oncology Commission. Lancet Oncol 2021; 22(4).

3. Abrokwa SK, Ruby LC, Heuvelings CC, Bélard S. Task shifting for point-of-care ultrasound in primary healthcare in low- and middle-income countries—a systematic review. EClinicalMedicine 2022;45:101333.

4. Rykkje A, Carlsen JF, Nielson MB. Hand-held ultrasound devices compared with high-end ultrasound systems: A systematic review. Diagnostics (Basel) 2019;9(2):61.

5. Tran TT, Hlaing M, Krause M. Point-of-care ultrasound: Applications in low- and middle-income countries. Curr Anesthesiol Rep 2021;11(1):69–75.

6. United Nations. The 2023 Agenda for Sustainable Development. 2023. Available from: https://sustainabledevelopment.un.org/content/documents/21252030%20Agenda%20for%20Sustainable%20Development%20web.pdf.

7. Knights S, Prasad S, Kalafat E, Dadali A, Sizer P, Harlow F, Khalil A. Impact of point-of-care ultrasound and routine third trimester ultrasound on undiagnosed breech presentation and perinatal outcomes: An observational multicentre cohort study. PLoS Med 2023;20(4).

8. Lozeau AM, Potter B. Diagnosis and management of ectopic pregnancy. American Family Physician 2005;72(9):1707–1714.

9. World Health Organization. Imaging ultrasound before 24 weeks of pregnancy: 2022 update to the WHO antenatal care recommendations for a positive pregnancy experience. World Health Organization; 2022. Available from: https://www.who.int/publications/i/item/9789240051461

10. Ross AB, DeStigter KK, Rielly M, Souza S, Morey GE, Nelson M, Silfen EZ, Garra B, Matovu A, Kawooya MG. A low-cost ultrasound program leads to increased antenatal clinic visits and attended deliveries at a health care clinic in rural Uganda. PLoS One 2023.

11. Shokoohi H, Raymond A, Fleming K, Scott J, Kerry V, Haile-Mariam T, Sayeed S, Boniface KS. Assessment of point-of-care ultrasound training for clinical educators in Malawi, Tanzania, and Uganda. Ultrasound Med Biol 2019;45(6):1351–1357.

12. Waiswa P, Akuze J, Moyer C, Kwesiga D, Arthur S, Sankoh O, Welaga P, Bangha M, Eminas J, Muuo S, Ziraba A, Kerber K; INDEPTH Network MNCH team. Status of birth and pregnancy outcome capture in Health Demographic Surveillance Sites in 13 countries. Int J Public Health 2019;64(6):909–920.

13. United Nations. Levels and trends in child mortality. 2019. Available from: https://www.unicef.org/media/60561/file/UN-IGME-child-mortality-report-2019.pdf.

14. Pattinson R, Fawcus S, Gebhardt S, Soma-Pillay P, Niit R, Moodley J. The impact of COVID-19 on use of maternal and reproductive health services and maternal and perinatal mortality. South African Health Review 2021.

15. World Health Organization. Newborn mortality. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/levels-and-trends-in-child-mortality-report-2021#:~:text=Preterm%20birth%2C%20intrapartum%2Drelated%20complicationscauses%20of%20most%20neonatal%20deaths.

16. Dhaded SM, Somannavar MS, Vernekar SS, Goudar SS, Mwenche M, Derman R, Moore JL, Patel A, Pasha O, Esamai F, Garces A, Althabe F, Chomba E, Liechty EA, Hambidge KM, Krebs NF, Berrueta M, Ciganda A, Hibberd PL, Goldenberg RL, McClure EM, Koso-Thomas M, Manasyan A, Carlo WA. Neonatal mortality and coverage of essential newborn interventions 2010–2013: A prospective population-based study from low-middle income countries. Reprod Health 2015;12 Suppl 2(Suppl 2).

17. Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller AB, Kinney M, Lawn J; Born Too Soon Preterm Birth Action Group. Born too soon: The global epidemiology of 15 million preterm births. Reprod Health 2013;10 Suppl 1(Suppl 1).

18. Grytten J, Skau I, Sørensen R, Eskild A. Does the use of diagnostic technology reduce fetal mortality? Health Serv Res 2018;53(6):4437–4459.

19. Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, Lawn JE, Cousens S, Mathers C, Black RE. Global, regional, and national causes of under-5 mortality in 2000–15: An updated systematic analysis with implications for the Sustainable Development Goals. Lancet 2016;388(10063):3027–3035.

20. World Health Organization. Child mortality (under 5 years). 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/levels-and-trends-in-child-under-5-mortality-in-2020#:~:text=Globally%2C%20infectious%20diseases%2C%20including%20pneumoniafor%20children%20under%205%20years.

21. Jones BP, Tay ET, Elikashvili I, Sanders JE, Paul AZ, Nelson BP. Feasibility and safety of substituting lung ultrasonography for chest radiography when diagnosing pneumonia in children: A randomized controlled trial. Chest 2016;150(1):131–138.

22. Pourmand A, Pyle M, Yamane D, Sumon K, Frasure SE. The utility of point-of-care ultrasound in the assessment of volume status in acute and critically ill patients. World J Emerg Med 2019;10(4):232–238.

23. Stolz LA, Kizza H, Little K, Kasekende J. Intussusception detected with ultrasound in a resource-limited setting. Lancet 2013;381(9882):2054.

24. Gingrich AS, Saul T, Lewiss RE. Point-of-care ultrasound in a resource-limited setting: Diagnosing intussusception. J Emerg Med 2013;45(3).

25. UNAIDS. UNAIDS data 2022. 2022. Available from: https://www.unaids.org/sites/default/files/media_asset/data-book-2022_en.pdf.

26. World Health Organization. Tuberculosis. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis.

27. Heller T, Wallrauch C, Brunetti E, Giordani MT. Changes of FASH ultrasound findings in TB-HIV patients during anti-tuberculosis treatment. Int J Tuberc Lung Dis 2014;18(7):837–839.

28. Kahn D, Pool KL, Phiri L, Chibwana F, Schwab K, Longwe L, Banda BA, Gama K, Chimombo M, Chipungu C, Grotts J, Schooley A, Hoffman RM. Diagnostic ultrasound for high-risk patients and populations in Malawi: 2010–2018. PLoS Negl Trop Dis 2022;16(5).

29. Bélard S, Tamarozzi F, Bustinduy AL, Wallrauch C, Grobusch MP, Kuhn W, Brunetti E, Joekes E, Heller T. Point-of-care ultrasound assessment of tropical infectious diseases—A review of applications and perspectives. Am J Trop Med Hyg 2016;94(1):8–21.

30. Mohammed R, Gebrewold Y, Schuster A, Fikre H, Mekonnen T, Mulaw T, Bogale T, Vogt F, Diro E, van Griensven J. Abdominal ultrasound in the diagnostic work-up of visceral leishmaniasis and for detection of complications of spleen aspiration. PLoS Negl Trop Dis 2021;15(2).

31. Bélard S, Stratta E, Zhao A, Ritmeijer K, Moretó-Planas L, Fentress M, Nadimpalli A, Grobusch MP, Heller T, Heuvelings CC. Sonographic findings in visceral leishmaniasis—A narrative review. Travel Med Infect Dis 2020;39:101924.

32. Michels M, Sumardi U, de Mast Q, Jusuf H, Puspita M, Warma Dewi IM, Sinarta S, Alisjahbana B, van der Ven AJAM. The predictive diagnostic value of serial daily bedside ultrasonography for severe dengue in Indonesian adults. PLoS Negl Trop Dis 2013;7(6).

33. Dewan N, Zuluaga D, Osorio L, Krienke ME, Bakker C, Kirsch J. Ultrasound in dengue: A scoping review. Am J Trop Med Hyg 2021;104(3):826–835.

34. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis JR, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundström J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global burden of cardiovascular diseases and risk factors 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol 2020;76(25):2982–3021.

35. Inglis J, Boll K, Mohamed AM, Fraden M, Madar A, Merjavy S, Hirsi AA, Haldeman MS, Hategeka C. Assessing the efficacy of POCUS training in the Republic of Somaliland: a retrospective analysis of 500 scans conducted by general practitioners. Australas J Ultrasound Med. 2025;28(3):e70022. doi: 10.1002/ajum.70022

36. Nascimento BR, Sable C, Nunes MCP, Oliveira KKB, Franco J, Barbosa MM, Reese AT, Diamantino AC, Ferreira Filho DSG, Macedo FVB, Raso LAM, Paiva SMW, Ribeiro ALP, Beaton AZ; PROVAR+ (Programa de RastreamentO da VAlvopatia Reumática e outras Doenças Cardiovasculares) investigators. Echocardiographic screening of pregnant women by non-physicians with remote interpretation in primary care. Fam Pract. 2021;38(3):225-230. doi: 10.1093/fampra/cmaa115

37. Muhame RM, Dragulescu A, Nadimpalli A, Martinez D, Bottineau MC, Venugopal R, Runeckles K, Manlhiot C, Nield LE. Cardiac point of care ultrasound in resource limited settings to manage children with congenital and acquired heart disease. Cardiol Young. 2021;31(10):1651-1657. doi: 10.1017/S1047951121000834

38. Huson MAM, Kaminstein D, Kahn D, Belard S, Ganesh P, Kandoole-Kabwere V, Wallrauch C, Phiri S, Kreuels B, Heller T. Cardiac ultrasound in resource-limited settings (CURLS): towards a wider use of basic echo applications in Africa. Ultrasound J. 2019;11(1):34. doi: 10.1186/s13089-019-0149-0

39. Hamill C, Ellis PK, Johnston PC. Point of care thyroid ultrasound (POCUS) in endocrine outpatients: A pilot study. Ulster Med J 2020;89(1):21–24.

40. Kidder Bukhman A, Nsengimana VJP, Lipsitz MC, Henwood PC, Tefera E, Rouhani SA, Dukundane D, Bukhman GY. Diagnosis and management of acute heart failure in sub-Saharan Africa. Curr Cardiol Rep 2019;21(10):120.

41. World Health Organization. Injuries and violence. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/injuries-and-violence#:~:text=Injuries%E2%80%93bothunintentionalandviolencetrafficinjuries,homicideandsuicide.

42. Humbal H, Parikh R, Patel RB, Pancholi SH, Saxena K, Chawada A. Utility of point-of-care ultrasound in differentiating causes of shock in resource-limited setup. J Emerg Trauma Shock 2019;12(1):10–17.

43. Wang LJ, Chen LM, Chen Y, Bao LY, Zheng NN, Wang YZ, Xing YQ. Ultrasonography assessments of optic nerve sheath diameter as a noninvasive and dynamic method of detecting changes in intracranial pressure. JAMA Ophthalmol 2018;136(3):250–256.

44. Harbison H, Shah S, Marill K, Noble V. Correlation of optic nerve sheath diameter with direct measurement of intracranial pressure. Acad Emerg Med 2008;15(2):201–204.

45. Maissan I, Dirven PJAC, Haitsma IK, Hoeks SE, Gommers D, Stolker RJ. Ultrasonographically measured optic nerve sheath diameter as an accurate and quick monitor for changes in intracranial pressure. J Neurosurg 2015;123(3):743–747.

46. Ang SH, Lee SW, Lam KY. Ultrasound-guided reduction of distal radius fractures. J Med Ultrasound 2009;17(3):73–76.

47. Ramsingh D, Mangunta VR. The use of point-of-care ultrasonography in trauma anesthesia. Anesthesiol Clin 2019;37(1):93–106.

48. Nowitzki KM, Hoimes ML, Chen B, Zheng LZ, Kim YH. Ultrasonography of intrauterine devices. Ultrasonography 2015;34(3):183–194.

49. Baradwan S, Alshahrani MS, Alnoury A, Khadawardi K, Khan MA, Abdelkader RAA, Saleh OI, Galal HM, Mohamed SMA, Abdelhakim AM, Elgedawy AM, Elbahie AM, Gaber MA, Magdy AA, Shaheen K. Does ultrasound guidance provide pain relief during intrauterine contraceptive device insertion? A systematic review and meta-analysis of randomized controlled trials. J Ultrasound Med 2023;42(7):1401–1411.

50. Lentz B, Fong T, Rhyne R, Risko N. A systematic review of the cost-effectiveness of ultrasound in emergency care settings. Ultrasound J 2021;13(1):16.

51. Maganti K, Chen C, Jamthikar AD, Parikh P, Yanamala N, Sengupta PP. Cardiopulmonary point-of-care ultrasonography for hospitalist management of undifferentiated dyspnea. JAMA Netw Open. 2025;8(9):e2530677. doi:10.1001/jamanetworkopen.2025.30677.

52. European Commission. Restriction of Hazardous Substances in Electrical and Electronic Equipment (RoHS). 2023. Available from: https://environment.ec.europa.eu/topics/waste-and-recycling/rohs-directive_en.

53. Nolting L, Baker D, Hardy Z, Kushinka M, Brown HA. Solar-powered point-of-care sonography: Our Himalayan experience. J Ultrasound Med 2019;38(9):2477–2484.

54. Matthay MA, Arabi Y, Arroliga AC, Bernard G, Bersten AD, Brochard L. A new global definition of acute respiratory distress syndrome. Am J Respir Crit Care Med 2023.

55. Broderick JC, Mancha F, Long BJ, Maddry JK, Chung KK, Schauer SG. Combat trauma-related acute respiratory distress syndrome: A scoping review. Crit Care Explor 2022;4(9).

56. Liu JX, Goryakin Y, Maeda A, Bruckner T, Scheffler R. Global health workforce labor market projections for 2030. Hum Resour Health 2017;15(1):11.

57. Stolz LA, Muruganandan KM, Bisanzo MC, Sebikali MJ, Dreifuss BA, Hammerstedt HS, Nelson SW, Nayabale I, Adhikari S, Shah SP. Point-of-care ultrasound education for non-physician clinicians in a resource-limited emergency department. Trop Med Int Health 2015;20(8):1067–1072.

58. Lipsitz M, Levin L, Sharma V, Herrala J, Rimawi A, Bernier D, Kimberly H, Thomson A, Soucy Z, Henwood P. The state of point-of-care teleultrasound use for educational purposes: A scoping review. J Ultrasound Med 2022;41(8):1889–1906.

59. Dohlman L, DiMeglio M, Hajj J, Laudanski K. Global brain drain: How can the Maslow theory of motivation improve our understanding of physician migration? Int J Environ Res Public Health 2019;16(7):1182.

60. Hussain A, Via G, Melniker L, Goffi A, Tavazzi G, Neri L, Villen T, Hoppmann R, Mojoli F, Noble V, Zieleskiewicz L, Blanco P, Ma IWY, Wahab MA, Alsaawi A, Al Salamah M, Balik M, Barca D, Bendjelid K, Bouhemad B, Bravo-Figueroa P, Breitkreutz R, Calderon J, Connolly J, Copetti R, Corradi F, Dean AJ, Denault A, Govil D, Graci C, Ha YR, Hurtado L, Kameda T, Lanspa M, Laursen CB, Lee F, Liu R, Meineri M, Montorfano M, Nazerian P, Nelson BP, Neskovic AN, Nogue R, Osman A, Pazeli J, Pereira-Junior E, Petrovic T, Pivetta E, Poelaert J, Price S, Prosen G, Rodriguez S, Rola P, Royse C, Chen YT, Wells M, Wong A, Xiaoting W, Zhen W, Arabi Y. Multi-organ point-of-care ultrasound for COVID-19 (PoCUS4COVID): International expert consensus. Crit Care 2020;24(1):702.

61. Pivetta E, Goffi A, Tizzani M, Locatelli SM, Porrino G, Losano I, Leone D, Calzolari G, Vesan M, Steri F, Ardito A, Capuano M, Gelardi M, Silvestri G, Dutto S, Avolio M, Cavallo R, Bartalucci A, Paglieri C, Morello F, Richiardi L, Maule MM, Lupia E. Lung ultrasonography for the diagnosis of SARS-CoV-2 pneumonia in the emergency department. Ann Emerg Med 2021;77(4):385–394.

62. Shumbusho JP, Duanmu Y, Kim SH, Bassett IV, Boyer EW, Ruutiainen AT, Riviello R, Ntirenganya F, Henwood PC. Accuracy of resident-performed point-of-care lung ultrasound examinations versus chest radiography in pneumothorax follow-up after tube thoracostomy in Rwanda. J Ultrasound Med 2020;39(3):499–506.

63. Lam J, Wong S, Grubic N, Nihal S, Herr JE, Belliveau DJ, Gauthier S, Montague SJ, Johri AM. Accelerated remote consultation tele-POCUS in cardiopulmonary assessment (ARCTICA). POCUS J 2020;5(2):55–58.

64. Shah S. Implementing ultrasound in developing countries. In: Cosby K, Kendall J, editors. Practical guide to emergency ultrasound. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2014.

65. World Health Organization. Delivered by women, led by men. 2023. Available from: https://iris.who.int/bitstream/handle/10665/311322/9789241515467-eng.pdf?ua=1.

66. Rijken MJ, Gilder ME, Thwin MM, Ladda Kajeechewa HM, Wiladphaingern J, Lwin KM, Jones C, Nosten F, McGready R. Refugee and migrant women’s views of antenatal ultrasound on the Thai Burmese border: A mixed methods study. PLoS One 2012;7(4).

67. Jordan K, Lewis T, Roberts B. Quality in crisis: A systematic review of the quality of health systems in humanitarian settings. Confl Health 2021;15(1):7.

68. Borriello G, Guccione J, Di Loria A, Bosco A, Pepe P, Prisco F, Cringoli G, Paciello O, Rinaldi L, Ciaramella P. Fast focus ultrasound liver technique for the assessment of cystic echinococcosis in sheep. MDPI 2021;11(2):452.

69. Macpherson C, Bartholomot B, Frider B. Application of ultrasound in diagnosis, treatment, epidemiology, public health, and control of Echinococcus granulosus and E. multilocularis. Parasitology 2003;127 Suppl.

70. Rothberg JM, Ralston TS, Rothberg AG, Martin J, Zahorian JS, Alie SA, Sanchez NJ, Chen K, Chen C, Thiele K, Grosjean D, Yang J, Bao L, Schneider R, Schaetz S, Meyer C, Neben A, Ryan B, Petrus JR, Lutsky J, McMahill D, Corteville G, Hageman MR, Miller L, Fife KG. Ultrasound-on-chip platform for medical imaging, analysis, and collective intelligence. Proc Natl Acad Sci U S A. 2021;118(27):e2019339118. doi: 10.1073/pnas.2019339118.

71. Stringer JSA, Pokaprakarn T, Prieto JC, Vwalika B, Chari SV, Sindano N, Freeman BL, Sikapande B, Davis NM, Sebastião YV, Mandona NM, Stringer EM, Benabdelkader C, Mungole M, Kapilya FM, Almnini N, Diaz AN, Fecteau BA, Kosorok MR, Cole SR, Kasaro MP. Diagnostic accuracy of an integrated AI tool to estimate gestational age from blind ultrasound sweeps. JAMA. 2024;332(8):649-657. doi: 10.1001/jama.2024.10770

72. Suttels V, Du Toit JD, Fiogbé AA, Wachinou AP, Guendehou B, Alovokpinhou F, Toukoui P, Hada AR, Sefou F, Vinasse P, Makpemikpa G, Capo-Chichi D, Garcia E, Brahier T, Keitel K, Ouattara K, Cissoko Y, Beye SA, Mans PA, Agodokpessi G, Boillat-Blanco N, Hartley MA. Point-of-care ultrasound for tuberculosis management in Sub-Saharan Africa-a balanced SWOT analysis. Int J Infect Dis. 2022;123:46-51. doi: 10.1016/j.ijid.2022.07.009. PMID: 35811083.

73. Ghent University. Comparative efficacy of CUS, CXR and CAD in TB diagnosis in LMIC [Internet]. 2024 May 14. Available from: https://clinicaltrials.gov/study/NCT06409780. ClinicalTrials.gov identifier: NCT06409780.

74. Suttels V, Wachinou P, Toit JD, Boillat-Blanco N, Hartley MA. Ultrasound for point-of-care sputum-free tuberculosis detection: building collaborative standardized image-banks. EBioMedicine. 2022;81:104078. doi: 10.1016/j.ebiom.2022.104078

75. World Health Organization. The top 10 causes of death. 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.

76. Githemo G, Wanyoro A, Masika J, Onsongo L, Bett S, Githuku S, Gachuiri G, Walker D, Santos N, Ghosh R, Otieno G. Evaluation of large-scale implementation of obstetric point of care ultrasound in eight counties in Kenya using RE-AIM framework. BMC Health Serv Res. 2025;25:1016. doi: 10.1186/s12913-025-13212-8

77. Smith M, Krishnan SV, Leamon A, Galwankar S, Sinha TP, Kumar VA, Laere JV, Gallien J, Bhoi S. Removing barriers to emergency medicine point-of-care ultrasound: Illustrated by a roadmap for emergency medicine point-of-care ultrasound expansion in India. J Emerg Trauma Shock 2023;16(3):116–126.

78. Suttels V, Guedes Da Costa S, Garcia E, Brahier T, Hartley MA, Agodokpessi G, Wachinou P, Fasseur F, Boillat-Blanco N. Barriers and facilitators to implementation of point-of-care lung ultrasonography in a tertiary centre in Benin: A qualitative study among general physicians and pneumologists. BMJ Open 2023;13(6):e070765.

79. Wanjiku GW, Bell G, Wachira B. Assessing a novel point-of-care ultrasound training program for rural healthcare providers in Kenya. BMC Health Serv Res 2018;18:607.

80. Dougherty A, Kasten M, DeSarno M, Badger G, Streeter M, Jones DC, Sussman B, DeStigter K. Validation of a telemedicine quality assurance method for point-of-care obstetric ultrasound used in low-resource settings. J Ultrasound Med 2021;40(3):529–540.

81. World Health Organization. Strengthening diagnostics capacity. 2023. Available from: https://apps.who.int/gb/ebwha/pdf_files/EB152/B152(6)-en.pdf.

82. Lancet Oncology Commission on Medical Imaging and Nuclear Medicine. WHA Resolution [Internet]. Vienna: Imaging Commission; 2025. Available from: https://imagingcommission.org/wha-resolution-2/

83. United Nations. The Secretary-General’s strategy on new technologies. 2023. Available from: https://www.un.org/en/un-chronicle/secretary-general%E2%80%99s-strategy-new-technologies-0.

84. Chavez MA, Shams N, Ellington LE, Naithani N, Gilman RH, Steinhoff MC, Santosham M, Black RE, Price C, Gross M, Checkley W. Lung ultrasound for the diagnosis of pneumonia in adults: A systematic review and meta-analysis. Respir Res 2014;15(1):50.

85. Ye X, Xiao H, Chen B, Zhang S. Accuracy of lung ultrasonography versus chest radiography for the diagnosis of adult community-acquired pneumonia: Review of the literature and meta-analysis. PLoS One 2015;10(6).

86. Yan JH, Yu N, Wang YH, Gao YB, Pan L. Lung ultrasound vs chest radiography in the diagnosis of children pneumonia. Medicine (Baltimore) 2020;99(50).

87. Schaad S, Brahier T, Hartley MA, Cordonnier JB, Bosso L, Espejo T, Pantet O, Hugli O, Carron PN, Meuwly JY, Boillat-Blanco N. Point-of-care lung ultrasonography for early identification of mild COVID-19: A prospective cohort of outpatients in a Swiss screening center. BMJ Open 2022;12(6).

88. Peixoto AO, Costa RM, Uzun R, Fraga AMA, Ribeiro JD, Marson FAL. Applicability of lung ultrasound in COVID-19 diagnosis and evaluation of the disease progression: A systematic review. Pulmonology 2021;27(6):529–562.

89. Fang HY, Chang KW, Chao YK. Ultrasound-guided pleural effusion drainage: Effect on oxygenation, respiratory mechanics, and liberation from mechanical ventilation in surgical intensive care unit patients. Diagnostics (Basel) 2021;11(11):2000.

90. Demi L, Wolfram F, Klersy C, De Silvestri A, Ferretti VV, Muller M, Miller D, Feletti F, Wełnicki M, Buda N, Skoczylas A, Pomiecko A, Damjanovic D, Olszewski R, Kirkpatrick AW, Breitkreutz R, Mathis G, Soldati G, Smargiassi A, Inchingolo R, Perrone T. New international guidelines and consensus on the use of lung ultrasound. J Ultrasound Med 2023;42(2):309–344.

91. Volpicelli G, Caramello V, Cardinale L, Mussa A, Bar F, Frascisco MF. Bedside ultrasound of the lung for the monitoring of acute decompensated heart failure. Am J Emerg Med 2008;26(5):585–591.

92. Kent A, Patil P, Davila V, Bailey JK, Jones C, Evans DC, Boulger CT, Adkins E, Balakrishnan JM, Valiyaveedan S, Galwankar SC, Bahner DP, Stawicki SP. Sonographic evaluation of intravascular volume status: Can internal jugular or femoral vein collapsibility be used in the absence of IVC visualization? Ann Thorac Med. 2015;10(1):44-9. doi:10.4103/1817-1737.146872

93. Shah SP, Shah SP, Fils-Aime R, Desir W, Joasil J, Venesy DM, Muruganandan KM. Focused cardiopulmonary ultrasound for assessment of dyspnea in a resource-limited setting. Crit Ultrasound J 2016;8(1):7.

94. Vafaie M. State-of-the-art diagnosis of myocardial infarction. Diagnosis (Berl) 2016;3(4):137–142.

95. Yu AR, Hasjim B, Yu LE, Gabriel C, Anshus A, Lee JB, Louthan MJ, Kim EC, Lee K, Tse C, Keown T, Lahham S, Alvarado M, Bunch S, Gari A, Fox JC. Comparison of ultrasound-measured properties of the common carotid artery to tobacco smoke. exposure in a cohort of Indonesian patients. World J Emerg Med 2017;8(3):177–183.

96. Pugliese CM, Adegbite BR, Edoa JR, Mombo-Ngoma G, Obone-Atome FA, Heuvelings CC, Bélard S, Kalkman LC, Leopold SJ, Hänscheid T, Adegnika AA, Huson MA, Grobusch MP. Point-of-care ultrasound to assess volume status and pulmonary oedema in malaria patients. Infection 2022;50(1):65–82.

97. Beare NA, Glover SJ, Lewallen S, Taylor TE, Harding SP, Molyneux ME. Prevalence of raised intracranial pressure in cerebral malaria detected by optic nerve sheath ultrasound. Am J Trop Med Hyg 2012;87(6):985–988.

98. Murphy S, Cserti-Gazdewich C, Dhabangi A, Musoke C, Nabukeera-Barungi N, Price D, King ME, Romero J, Noviski N, Dzik W. Ultrasound findings in Plasmodium falciparum malaria: A pilot study. Pediatr Crit Care Med 2011;12(2).

99. Levine AC, Shah SP, Umulisa I, Munyaneza RB, Dushimiyimana JM, Stegmann K, Musavuli J, Ngabitsinze P, Stulac S, Epino HM, Noble VE. Ultrasound assessment of severe dehydration in children with diarrhea and vomiting. Acad Emerg Med 2010;17(10):1035–1041.

100. Modi P, Glavis-Bloom J, Nasrin S, Guy A, Chowa EP, Dvor N, Dworkis DA, Oh M, Silvestri DM, Strasberg S, Rege S, Noble VE, Alam NH, Levine AC. Accuracy of inferior vena cava ultrasound for predicting dehydration in children with acute diarrhea in resource-limited settings. PLoS One 2016;11(1).

101. Kołodziej M, Jalali A, Łukasik J. Point-of-care ultrasound to assess the degree of dehydration in children: A systematic review with meta-analysis. Arch Dis Child 2024;109(4):275–281.

102. Gottlieb M, Peksa GD, Pandurangadu AV, Nakitende D, Takhar S, Seethala RR. Utilization of ultrasound for the evaluation of small bowel obstruction: A systematic review and meta-analysis. Am J Emerg Med 2018;36(2):234–242.

103. Giannelli F, Cozzi D, Cavigli E, Campolmi I, Rinaldi F, Giachè S, Rogasi PG, Miele V, Bartolucci M. Lung ultrasound (LUS) in pulmonary tuberculosis: Correlation with chest CT and X-ray findings. J Ultrasound 2022;25(3):625–634.

104. Fentress M, Ugarte-Gil C, Cervantes M, Rivas D, Moore D, Caliguiri P, Bergman K, Noazin S, Padovani A, Gilman RH. Lung ultrasound findings compared with chest X-ray findings in known pulmonary tuberculosis patients: A cross-sectional study in Lima, Peru. Am J Trop Med Hyg 2020;103(5):1827–1833.

105. Donovan J, Oanh PKN, Dobbs N, Phu NH, Nghia HDT, Summers D, Thuong NTT, Thwaites GE; Vietnam ICU Translational Applications Laboratory (VITAL) Investigators. Optic nerve sheath ultrasound for the detection and monitoring of raised intracranial pressure in tuberculous meningitis. Clin Infect Dis 2021;73(9).

106. Bobbio F, Di Gennaro F, Marotta C, Kok J, Akec G, Norbis L, Saracino A, Mazzucco W, Lunardi M. Focused ultrasound to diagnose HIV-associated tuberculosis (FASH) in the extremely resource-limited setting of South Sudan: A cross-sectional study. BMJ Open 2019;9(4).

107. Heller T, Wallrauch C, Goblirsch S, Brunetti E. Focused assessment with sonography for HIV-associated tuberculosis (FASH): A short protocol and a pictorial review. Crit Ultrasound J 2012;4(1):21.

108. Luntsi G, Ugwu AC, Ahmadu MS, Ohagwu CC, Sidi M, Ochie K, Mshelia EP, Erim AE, Abubakar U, Nkubli FB, Nwobi CI, Ayogu E. Routine ultrasonography for intensified tuberculosis case finding in high HIV and TB burdened countries: A proposed framework. J Med Ultrasound 2022;30(4):245–250.

109. Huson MAM, Kumwenda T, Gumulira J, Rambiki E, Wallrauch C, Heller T. Ultrasound findings in Kaposi sarcoma patients: Overlapping sonographic features with disseminated tuberculosis. Ultrasound J 2023;15(1):27.

110. Netherton S, Milenkovic V, Taylor M, Davis PJ. Diagnostic accuracy of eFAST in the trauma patient: A systematic review and meta-analysis. CJEM 2019;21(6):727–738.

111. Huson M, Rokx C. Exploring the role of point-of-care ultrasound for people with HIV in a resource-affluent setting: A prospective observational study. Int J STD AIDS 2023;34(13):984–989.

112. Waheed S, Atta MG. Predictors of HIV-associated nephropathy. Expert Rev Anti Infect Ther 2014;12(5):555–563.

113. Sud K, Argulian E. Echocardiography in patients with HIV infection. Curr Cardiol Rep 2020;22(9):100.

114. Vululi ST, Bugeza S, Zeridah M, Ddungu H, Openy AB, Frank M, Parkes-Ratanshi R. Prevalence of lower limb deep venous thrombosis among adult HIV-positive patients attending an outpatient clinic at Mulago Hospital. AIDS Res Ther 2018;15(1):3.

115. Marggrander DT, Koç-Günel S, Tekeli-Camcı N, Martin S, Golbach R, Wolf T. Lung ultrasound effectively detects HIV-associated interstitial pulmonary disease. Int J Infect Dis 2021;111:204–210.

116. Salim I, Staines-Urias E, Mathewlynn S, Drukker L, Vatish M, Impey L. The impact of a routine late third trimester growth scan on the incidence, diagnosis, and management of breech presentation in Oxfordshire, UK: A cohort study. PLoS Med. 2021 Jan 15;18(1):e1003503. doi: 10.1371/journal.pmed.1003503

117. Ekéus C, Norman M, Åberg K, Winberg S, Stolt K, Aronsson A. Vaginal breech delivery at term and neonatal morbidity and mortality—a population-based cohort study in Sweden. J Matern Fetal Neonatal Med. 2019;32(2):265-270. doi: 10.1080/14767058.2017.1378328. PMID: 28889774.

118. Luterkort M, Polberger S, Persson PH, Bjerre I. Role of asphyxia and slow intrauterine growth in morbidity among breech delivered infants. Early Hum Dev. 1986 Jul;14(1):19-31. doi: 10.1016/0378-3782(86)90166-0

Posted in .

Leave a Reply

Your email address will not be published. Required fields are marked *